GlassScriptPhysician profile
Kyo U Chu
NPI 1841298957
$2,859.22
in general payments reported to CMS, 2019-2025
7 companies · $2,225 in 2025
The $2,225 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.88 · 2021: $32.65 · 2023: $383 · 2024: $122 · 2025: $2,225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,482 · Food and Beverage: $1,051 · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,481.88 |
| Food and Beverage | $1,050.86 |
| Education | $196.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $1,238.33 | 2025 | |
| Intuitive Surgical, INC. | $1,183.26 | 2023-2025 | |
| Ethicon US, LLC | $168.82 | 2019-2023 | Vistaseal, Surgicel Nu-Knit, Surgiflo Hemostatic Matrix |
| Sirtex Medical INC | $147.12 | 2023 | Sir-Spheres Microspheres |
| Intera Oncology, INC | $86.36 | 2024 | Intera |
| Baxter Healthcare | $17.98 | 2024 | Tisseel |
| Springworks Therapeutics, INC. | $17.35 | 2024 | Ogsiveo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyo Chu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.